| |
|
|
|
Catabasis Pharmaceuticals Inc.  
|
|
5.025 0.095 (0.02%) |
11-21 14:27 |
|
Open: |
4.95 |
Pre close: |
4.93 |
Target:
|
6.12 
|
|
High: |
5.08 |
Low: |
4.85 |
Resistance:
|
5.24
5.64
|
|
Volume: |
69,634 |
Market Cap: |
59M |
Support:
|
4.60
3.83
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.00
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
5.16 |
Signal(12,26,9): |
-0.01 |
|
MA(100): |
5.97 |
Stochastic Oscillator |
%K(14,3):
|
12.04 |
|
MA(250): |
6.26 |
%D(3): |
13.58 |
|
Average Volume(K) |
3-Month: |
8795
|
52-Week |
High:
|
9.76 |
|
10-Days: |
8447 |
Low: |
3.60 |
|
RSI |
RSI(14):
|
47.10 |
Change(%): |
-11.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.580 |
Return on Equity (ttm) |
-65.3 |
Shares Out. (M) |
11.80 |
|
EPS Est. Current Year |
-1.390 |
Return on Assets (ttm) |
-36.0 |
Shares Float (M) |
11.10 |
|
EPS Est. Next Year |
-1.100 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.87 |
|
EPS Est. Next Quarter |
-0.330 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
33.18 |
|
Forward EPS |
-1.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
463 |
|
Book Value (p.s.) |
3.270 |
EBITDA (p.s.) |
-2.161 |
P/E |
-1.95 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.54 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-24.07 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-15.80 |
P/CF |
-2.47 |
|
|
|
|
|
|
